303110-96-5

Upstream product

• 3988-03-2 bis(4-bromophenyl)methanone 
• 494865-05-3 ethyl 3,3-bis-(4-bromophenyl)-acrylate 

Downstream Products

• 494865-03-1 3-{3-[3,3-bis-(4-bromo-phenyl)-allyloxy]-phenyl}-propionic acid ethyl ester 
• 1265080-70-3 C₂₆H₃₀Br₂O 
• 1265081-11-5 C₂₆H₂₈Br₂O 
• 303110-76-1 (S)-ethyl-3-(4-(3,3-bis-(biphenyl-4-yl)allyloxy)phenyl)-2-ethoxy-propionate 
• 303110-84-1 (2S)-3-{4-[3,3-bis-(4-furan-2-yl-phenyl)-allyloxy]-phenyl}-2-ethoxy-propionic acid ethyl ester 
• 685138-99-2 methyl {4-[3,3-bis-(4-bromo-phenyl)-allylsulfanyl]-2-chloro-phenoxy}-acetate 
• 494865-21-3 ethyl {4-[3,3-bis-(4-bromo-phenyl)-allyloxy]-3-chloro-phenyl}-acetate 
• 494865-09-7 ethyl {3-[3,3-bis-(4-bromo-phenyl)-allyloxy]-phenyl}-acetate 
• 494865-16-6 methyl {4-[3,3-bis-(4-bromo-phenyl)-allyloxy]-phenyl}-acetate 
• 494865-12-2 ethyl 3-{4-[3,3-bis-(4-bromo-phenyl)-allyloxy]-phenyl}-propionate 
• 43007-89-2 3,3-bis-(biphenyl-4-yl)-pro-2-en-1-ol 
• 303110-78-3 (2S)-3-{4-[3,3-bis-(4-bromophenyl)-allyloxy]-phenyl}-2-ethoxy-propionic acid ethyl ester 
• 303111-03-7 3,3-bis-(4-furan-2-yl-phenyl)-prop-2-en-1-ol 
• 673479-09-9 {4-[3,3-Bis-(4-bromo-phenyl)-allylsulfanyl]-2-methyl-phenoxy}-acetic acid 

Relevant academic research and scientific papers

PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES

The preparation of an intermediate, a process for the preparation thereof and the process of preparing [4-[3,3-Bis-(4-bromo-phenyl)-allyloxy]-2-methyl-phenoxy]-acetic acid using this intermediate are described.

Identification and synthesis of a novel selective partial PPARδ agonist with full efficacy on lipid metabolism in vitro and in vivo

The aim was to identify a novel selective PPARδ agonist with full efficacy on free fatty acid (FFA) oxidation in vitro and plasma lipid correction in vivo. Using the triple PPARα,γ,δ agonist 1 as the structural starting point, we wanted to investigate the

Novel compounds, their preparation and use

Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be u

Novel compounds, their preparation and use

Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be u

NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR THERAPEUTICAL USE

Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may b

NOVEL COMPOUNDS, THEIR PREPARATION AND USE

Novel compounds of the general formula (I), the use of these compounds as pharma-ceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be

Novel compounds, their preparation and use

Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be u

NOVEL COMPOUNDS USEFUL IN TREATING PPAR MEDIATED DISEASES

Novel compounds of the general formula (I), the use of these compounds as pharma-ceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be

Design and synthesis of novel PPARα/γ/δ triple activators using a known PPARα/γ dual activator as structural template

Using a known dual PPARα/γ activator (5) as a structural template, SAR evaluations led to the identification of triple PPARα/γ/δ activators (18-20) with equal potency and efficacy on all three receptors. These compounds could become useful tools for studying the combined biological effects of PPARα/γ/δ activation.

Novel compounds, their preparation and use

Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be u